RT Journal Article
SR Electronic
T1 Catching a resurgence: Increase in SARS-CoV-2 viral RNA identified in wastewater 48 hours before COVID-19 clinical tests and 96 hours before hospitalizations
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.22.20236554
DO 10.1101/2020.11.22.20236554
A1 D’Aoust, Patrick M.
A1 Graber, Tyson E.
A1 Mercier, Elisabeth
A1 Montpetit, Danika
A1 Alexandrov, Ilya
A1 Neault, Nafisa
A1 Baig, Aiman Tariq
A1 Mayne, Janice
A1 Zhang, Xu
A1 Alain, Tommy
A1 Servos, Mark R.
A1 Srikanthan, Nivetha
A1 MacKenzie, Malcolm
A1 Figeys, Daniel
A1 Manuel, Douglas
A1 Jüni, Peter
A1 MacKenzie, Alex E.
A1 Delatolla, Robert
YR 2020
UL http://medrxiv.org/content/early/2020/11/23/2020.11.22.20236554.abstract
AB Curtailing the Spring 2020 COVID-19 surge required sweeping and stringent interventions by governments across the world. Wastewater-based COVID-19 epidemiology programs have been initiated in many countries to provide public health agencies with a complementary disease tracking metric and facile surveillance tool. However, their efficacy in prospectively capturing resurgence following a period of low prevalence is unclear. In this study, the SARS-CoV-2 viral signal was measured in primary clarified sludge harvested every two days at the City of Ottawa’s water resource recovery facility during the summer of 2020, when clinical testing recorded daily percent positivity below 1%. In late July, increases of >400% in normalized SARS-CoV-2 RNA signal in wastewater were identified 48 hours prior to reported >300% increases in positive cases that were retrospectively attributed to community-acquired infections. During this resurgence period, SARS-CoV-2 RNA signal in wastewater preceded the reported >160% increase in community hospitalizations by approximately 96 hours. This study supports wastewater-based COVID-19 surveillance of populations in augmenting the efficacy of diagnostic testing, which can suffer from sampling biases or timely reporting as in the case of hospitalization census.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by a CHEO (Children's Hospital of Eastern Ontario) CHAMO (Children's Hospital Academic Medical Organization) grant, awarded to Dr. Alex E. MacKenzie.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of Ottawa ethics committee was contacted regarding wastewater sampling and it was identified that no ethical concerns were present as our tests represented over 900,000 people, with no risk of singling out individuals or communities.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available upon request, and most up to date data available live at www.613covid.ca/wastewater http://www.613covid.ca/wastewater